In February, TheONC surveyed more than 600 oncology nurses to find out more about their careers. We wanted to know if they felt adequately compensated and satisfied within their profession.
Some of the questions we asked: What degrees do you hold? How much are you making? When was the last time you received a raise? Are you happy with your career?
You can find out the answers and more in the following slideshow, and you can see how your own career track matches up with that of your peers.
Click on the image below to start the slideshow of survey results.
Do you feel that the survey results are an accurate reflection of you and your work environment? If not, what are your personal observations and experiences?
More Blogs from...
TheONC editor Michelle Bragazzi discusses a study linking HCT and depression fatigue.
Community editor Michelle Bragazzi discusses the impact of shift hours in nursing care.
Community editor Michelle Bragazzi talks about what not to say to patients and families that are grieving or coping with a cancer diagnosis.
Community editor Michelle Bragazzi summarizes advice from experienced nurses to help nurses new to oncology.
Community editor Michelle Bragazzi wants to know if you're attending the 2015 ONS Annual Congress meeting in Orlando this week.
Tuesday, October 29, 2013 12:00 PM EDT
Ellen T. Matloff, MS, CGC , this webinar will highlight:
How to determine which patients require genetic counseling
How to help prepare your patients for the genetic counseling process
Testing options that are now available
How you can utilize this data in managing your patients and their family members
Participants will also be able to ask questions during a live question and answer period with speaker
Ellen T. Matloff, MS, CGC .
Wednesday, August 28, 2013 12:00 PM EDT
Wednesday, June 26, 2013 12:00 PM EDT
Wednesday, April 10, 2013 12:00 PM EDT
Have a question or topic but don't want to write a blog? Post it on our readerboards and get
feedback from the community!
FDA Approves Onivyde for Advanced Pancreatic Cancer Marijke Vroomen Durning, RN, 10/27/2015
On October 22, 2015, the US Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection, Merrimack Pharmaceuticals, Inc.), in combination with fluorouracil ...